Popular Spanish medical oncologist and researcher, Jose Baselga is dead. He passed away today March 21 2021 at the age of 61.
No cause of death has been reported yet as of the time of filing this report but Spanish newspaper La Vanguardia reported that he died of Creutzfeldt-Jakob disease, a rapidly evolving degenerative neurological disorder.
Jose’s death news was announced by AstraZeneca, the company he had worked as executive vice president for research and development in oncology.
Who Is Jose Baselga?
Born in Barcelona, Jose Baselga was a Spanish medical oncologist and researcher who from 1959 till January 2019 had served as director of the Oncology Research and Development Unit of the AstraZeneca company.
He was also medical director of the Memorial Sloan-Kettering Cancer Center in New York until September 2018 -one of the most prestigious centres for clinical research related to cancer-, a position from which he resigned after the publication of information from ‘The New York Times and ‘ProPublica’ in which they accused the doctor of having received millionaire aid from the pharmaceutical industry without having reflected it in their research work, as is mandatory in the United States. The oncologist justified it as a failure.
He also served as Chief of the Division of Hematology-Oncology and Associate Director of the Massachusetts General Hospital Cancer Center and was Professor of Medicine at Harvard Medical School.
Jose’s research has led to substantial improvements in survival for patients with multiple types of breast cancer.
He founded the Vall d’Hebron Institute of Oncology at Vall d’Hebron University Hospital in Barcelona.
Dr Jose Resignation After Receiving $1.5M
Dr Jose Baselga took a decision in 2018 to resign as Chief medical officer after receiving $1.5M payments for-profit health care companies from the Memorial Sloan Kettering.
According to reports from a news article posted online, Jose resigned his position in the company over his failure to disclose payments from health care companies in dozens of research articles he wrote.
After his resignation from the Memorial Sloan Kettering Baselga was appointed as an executive at the pharmaceutical company AstraZeneca, where he oversees the development of its cancer drugs.
See Cristiano Ronaldo Preferred Coach For Man United Job
Manchester United striker, Cristiano Ronaldo, wants Luis Enrique to take over the coaching job of Manchester United following the sacking...
This Is Worse For Me – Solskjaer Breaks Silence After Their Historic Match Against Liverpool, Says They Performed Poorly
Chelsea Vs Norwich: Why We Didn’t Stop Scoring – Tuchel
UCL: J Cole Reveals Chelsea’s Two Most Important Players
Ballon d’Or: Why Benzema Deserves The Title – Modric
Winning The Ballon d’Or Have Been One Of My Childhood Dreams – Benzema
Brazil Legend, Ronaldo Declares His Candidate For Ballon d’Or, Excludes Messi
It Was Messed Up – Heavy Bitterly Speaks About Issue That Affected His Album Release
South African music producer, Heavy K has revealed that a lot turned out in relation to his upcoming album which...
Why I Wanted To Help Emtee Build Back Again – Cassper Nyovest
South African rapper, Cassper Nyovest has opened up on the reasons why he really wanted to help Emtee build back...
Vusi Nova Retracts His Words, Says He Is Not Rebranding Or Changing His Stage Name
Recall that a few days ago we reported that Vusi Nova is rebranding his musical career and also changing his...
Nokwazi Reveals The Condition She Was Into When She Wrote Siyabonga Song
South African songstress, Nokwazi has disclosed the condition she was into when she wrote the viral Siyabonga song. The singer...
Khuli Chana Is Opening A New Studio, See The Interior View (Photos)
Khuli Chana is about to take his musical career to the next level as he reveals that he is opening...
Cassper Nyovest Drops 70K Pounds For A Gold Necklace Says It’s An Early Birthday Gift For Himself
South African rapper, Cassper Nyovest is living his life as he splashes a whopping 70,000 silver pounds for a gold...
Chinese real estate giant, Evergrande shares rebounds at the just concluded Hong Kong stock market opening on Tuesday
Chinese real estate giant, Evergrande shares recovers at the Hong Kong stock market opening after a historic drop. During the...